US Tariffs Put S$4 Billion Worth of Singapore Pharma Exports at Risk — Exemption Talks in Progress
SINGAPORE — Pharmaceutical companies in Singapore are currently navigating a wave of uncertainty following the United States’ announcement of steep new tariffs on imported branded drugs. These tariffs — pegged at a staggering 100% — could impact nearly S$4 billion (RM13 billion) worth of Singapore’s pharmaceutical exports, putting jobs, innovation, and global supply chains at […]
Continue Reading